Zobrazeno 1 - 10
of 26
pro vyhledávání: '"AV Popa"'
Autor:
I. N. Serebryakova, MA Shervashidze, N. A. Kupryshina, LYu Grivtsova, NN Tupitsyn, AV Popa, B. V. Kurdyukov, AD Palladina, O. A. Chernysheva, E. N. Sholokhova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 79-85 (2018)
Background. Minimal residual disease (MRD) is an independent prognostic factor in acute lymphoblastic leukemia (ALL) in children. The immunological assessment of MRD cell count is based on aberrant immunophenotype of tumor lymphoblasts. However, in t
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 381-389 (2017)
Background & Aims. Despite significant success in the treatment of acute lymphoblastic leukemia (ALL) in children, relapses and drug resistance to the standard therapy remain the main cause of treatment failure. The addition of bortezomib to the comb
Autor:
TR Panferova, Alla M. Kovrigina, GL Menkevich, II Matveeva, Timur Teimurazovich Valiev, LYu Grivtsova, AV Popa, EV Mikhailova, NN Tupitsyn, TL Ushakova, I. N. Serebryakova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 218-226 (2017)
The diagnosis of myeloid tumors is based on a complex approach and causes significant difficulties especially in young children. Morphologic, immunologic, cytogenetic, molecular and biologic data on myeloid sarcoma are presented based on the literatu
Autor:
I. N. Serebryakova, O. A. Beznos, AV Popa, LYu Grivtsova, NN Tupitsyn, OYu Baranova, MA Shervashidze, EA Osmanov
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 158-168 (2017)
Background & Aims. Evaluation of the minimal residual disease (MRD) at different stages of chemotherapy is one of key prognostic factors and a factor of stratification of patients into risk groups in acute lymphoblastic leukemia (ALL). The MRD detect
Autor:
EV Fleishman, OI Sokova, AV Popa, GA Tsaur, LN Konstantinova, OM Plekhanova, MV Strigaleva, ES Nokhrina, VS Nemirovchenko, OR Arakaev
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 4, Pp 446-455 (2016)
Aim. To study characteristics of 11q23 involvement, age-specific differences in the incidence of these chromosomal markers in acute myeloid leukemias (AML) in children, and to determine their prognostic significance in patients treated according to t
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 2, Pp 199-207 (2016)
Anaplastic large cell lymphoma (ALCL) includes different types of the disease that are heterogeneous according to clinical, morphological, immunological, cytogenetic and molecular biological features. The review demonstrates not only main clinical an
Autor:
Ravshanova Rs, AV Popa, E S Belyaeva, G L Mentkevich, NS Kulichkina, T T Valiev, AS Levashov, BV Kurdyukov
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 4, Pp 420-437 (2016)
Background & Aims. Current polychemotherapeutic protocols based on differentiated and risk-adopted approaches permitted to consider non-Hodgkin's lymphomas (NHL) potentially curable diseases although they had been considered fatal previously. The aim
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 13-21 (2016)
Background & Aims. Most children with Hodgkin’s lymphoma (HL) can be cured irrespective of the disease stage using modern risk adapted protocols. But 3–5 % of children develop relapse of the disease or refractoriness to the treatment performed. T
Autor:
L. Yu Grivtsova, MA Shervashidze, O. A. Beznos, O. P. Grebennikova, I. N. Serebtyakova, AV Popa, G. V. Titova, V. U. Selchuk, N. N. Tupitsyn
Publikováno v:
Journal of Physics: Conference Series. 945:012003
Autor:
Petric PS; Facultatea de Medicină, Universitatea Transilvania din Brașov, Bulevardul Eroilor 29, 500036 Brașov, Romania.; Spitalul Clinic de Psihiatrie și Neurologie Brașov, Str. Prundului No. 7-9, 500123 Brașov, Romania., Ifteni P; Facultatea de Medicină, Universitatea Transilvania din Brașov, Bulevardul Eroilor 29, 500036 Brașov, Romania.; Spitalul Clinic de Psihiatrie și Neurologie Brașov, Str. Prundului No. 7-9, 500123 Brașov, Romania., Popa AV; Facultatea de Medicină, Universitatea Transilvania din Brașov, Bulevardul Eroilor 29, 500036 Brașov, Romania.; Spitalul Clinic de Psihiatrie și Neurologie Brașov, Str. Prundului No. 7-9, 500123 Brașov, Romania., Teodorescu A; Facultatea de Medicină, Universitatea Transilvania din Brașov, Bulevardul Eroilor 29, 500036 Brașov, Romania.; Spitalul Clinic de Psihiatrie și Neurologie Brașov, Str. Prundului No. 7-9, 500123 Brașov, Romania.
Publikováno v:
Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2024 Jul 05; Vol. 12 (13). Date of Electronic Publication: 2024 Jul 05.